| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOCN | Common Stock | Award | $0 | +5.42K | +14.96% | $0.00 | 41.6K | Jun 6, 2024 | See Footnote | F1, F2 |
| transaction | DOCN | Common Stock | Sale | -$196K | -5.22K | -12.54% | $37.46 | 36.4K | Jun 7, 2024 | See Footnote | F2, F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The security represents restricted stock units ("RSUs") issued to the Reporting Person pursuant to the annual grant under the Issuer's non-employee director compensation policy (the "Policy"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. Pursuant to the Policy, the number of shares of RSUs is equal to $200,000 divided by $36.92, the average of the closing price of the Issuer's common stock on the NYSE for the 10 trading days prior to and ending on the date of grant. The shares underlying these RSUs will vest on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's 2025 annual stockholders' meeting, subject to the Reporting Person's continuous service with the Issuer through the applicable vesting date. |
| F2 | Securities are held by Plato Partners LLC, of which the Reporting Person owns substantially all of the ownership interests. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. |
| F3 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $37.26-37.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. |